Global Sialylated Human Milk Oligosaccharides (HMO) Market Growth 2026-2032
The global Sialylated Human Milk Oligosaccharides (HMO) market size is predicted to grow from US$ 150 million in 2025 to US$ 442 million in 2032; it is expected to grow at a CAGR of 17.1% from 2026 to 2032.
In 2025, global Sialylated Human Milk Oligosaccharides (HMO) production reached approximately 802 tons, with an average global market price of around US$191 per kilogram. Sialylated HMOs are an important type of HMOs, accounting for approximately 13% of total HMOs. 3'-Sialyllactose (3'-SL) and 6?-sialyllactose (6'-SL) are two simplest sialylated HMOs.
The global market for sialylated Human Milk Oligosaccharides (HMOs) is shifting from basic supplementation toward specialized functional nutrition. Synthetic biology breakthroughs have established microbial fermentation as the dominant production route, with domestic pioneers achieving commercial production of synthetic HMO products and breaking previous import dependency. Kyowa Hakko Bio completed an HMO production facility in Thailand in 2022 and began commercial production there; in 2023 it received FDA no-question letters covering 3'-SL and 6'-SL for non-exempt infant formula and conventional foods, and in 2024 its 3'-SL and 6'-SL were already within the EU novel-food authorization framework, indicating that major-market access is opening. As a result, competition is shifting from simple capacity expansion to quality standards, regulatory capability, and supply reliability. Future growth will mainly come from infant nutrition and premium nutrition formulations that seek ingredients closer to human milk, together with broader approved food categories and geographies. At the same time, high purity requirements, complex processing, long approval cycles, cost pressure, and a still-concentrated supply base remain the main constraints. Overall, this segment is likely to expand through high-value, regulation-led, stepwise commercialization rather than rapid mass adoption.
LP Information, Inc. (LPI) ' newest research report, the ?Sialylated Human Milk Oligosaccharides (HMO) Industry Forecast? looks at past sales and reviews total world Sialylated Human Milk Oligosaccharides (HMO) sales in 2025, providing a comprehensive analysis by region and market sector of projected Sialylated Human Milk Oligosaccharides (HMO) sales for 2026 through 2032. With Sialylated Human Milk Oligosaccharides (HMO) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sialylated Human Milk Oligosaccharides (HMO) industry.
This Insight Report provides a comprehensive analysis of the global Sialylated Human Milk Oligosaccharides (HMO) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sialylated Human Milk Oligosaccharides (HMO) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Sialylated Human Milk Oligosaccharides (HMO) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sialylated Human Milk Oligosaccharides (HMO) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sialylated Human Milk Oligosaccharides (HMO).
This report presents a comprehensive overview, market shares, and growth opportunities of Sialylated Human Milk Oligosaccharides (HMO) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
In 2025, global Sialylated Human Milk Oligosaccharides (HMO) production reached approximately 802 tons, with an average global market price of around US$191 per kilogram. Sialylated HMOs are an important type of HMOs, accounting for approximately 13% of total HMOs. 3'-Sialyllactose (3'-SL) and 6?-sialyllactose (6'-SL) are two simplest sialylated HMOs.
The global market for sialylated Human Milk Oligosaccharides (HMOs) is shifting from basic supplementation toward specialized functional nutrition. Synthetic biology breakthroughs have established microbial fermentation as the dominant production route, with domestic pioneers achieving commercial production of synthetic HMO products and breaking previous import dependency. Kyowa Hakko Bio completed an HMO production facility in Thailand in 2022 and began commercial production there; in 2023 it received FDA no-question letters covering 3'-SL and 6'-SL for non-exempt infant formula and conventional foods, and in 2024 its 3'-SL and 6'-SL were already within the EU novel-food authorization framework, indicating that major-market access is opening. As a result, competition is shifting from simple capacity expansion to quality standards, regulatory capability, and supply reliability. Future growth will mainly come from infant nutrition and premium nutrition formulations that seek ingredients closer to human milk, together with broader approved food categories and geographies. At the same time, high purity requirements, complex processing, long approval cycles, cost pressure, and a still-concentrated supply base remain the main constraints. Overall, this segment is likely to expand through high-value, regulation-led, stepwise commercialization rather than rapid mass adoption.
LP Information, Inc. (LPI) ' newest research report, the ?Sialylated Human Milk Oligosaccharides (HMO) Industry Forecast? looks at past sales and reviews total world Sialylated Human Milk Oligosaccharides (HMO) sales in 2025, providing a comprehensive analysis by region and market sector of projected Sialylated Human Milk Oligosaccharides (HMO) sales for 2026 through 2032. With Sialylated Human Milk Oligosaccharides (HMO) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sialylated Human Milk Oligosaccharides (HMO) industry.
This Insight Report provides a comprehensive analysis of the global Sialylated Human Milk Oligosaccharides (HMO) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sialylated Human Milk Oligosaccharides (HMO) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Sialylated Human Milk Oligosaccharides (HMO) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sialylated Human Milk Oligosaccharides (HMO) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sialylated Human Milk Oligosaccharides (HMO).
This report presents a comprehensive overview, market shares, and growth opportunities of Sialylated Human Milk Oligosaccharides (HMO) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 3'-Sialyllactose (3'-SL)
- 6'-Sialyllactose (6'-SL)
- Microbial Fermentation
- Enzymatic Synthesis
- Food Grade
- Research Grade
- Infant Formula
- Food
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novonesis
- Inbiose
- DSM (Glycom A/S)
- Kyowa Hakko Bio
- GeneChem Inc.
- Elicityl
- Zhuhai Langjian Biotechnology
- Shanghai HuicH Biotech
- What is the 10-year outlook for the global Sialylated Human Milk Oligosaccharides (HMO) market?
- What factors are driving Sialylated Human Milk Oligosaccharides (HMO) market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How doSialylated Human Milk Oligosaccharides (HMO) market opportunities vary by end market size?
- How does Sialylated Human Milk Oligosaccharides (HMO) break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sialylated Human Milk Oligosaccharides (HMO) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Sialylated Human Milk Oligosaccharides (HMO) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Sialylated Human Milk Oligosaccharides (HMO) by Country/Region, 2021, 2025 & 2032
2.2 Sialylated Human Milk Oligosaccharides (HMO) Segment by Type
2.2.1 3'-Sialyllactose (3'-SL)
2.2.2 6'-Sialyllactose (6'-SL)
2.2.3 Sialylated Human Milk Oligosaccharides (HMO) Sales by Type
2.2.3.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2021-2026)
2.2.3.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sale Price by Type (2021-2026)
2.3 Sialylated Human Milk Oligosaccharides (HMO) Segment by Process
2.3.1 Microbial Fermentation
2.3.2 Enzymatic Synthesis
2.3.3 Sialylated Human Milk Oligosaccharides (HMO) Sales by Process
2.3.3.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Process (2021-2026)
2.3.3.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue and Market Share by Process (2021-2026)
2.3.3.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sale Price by Process (2021-2026)
2.4 Sialylated Human Milk Oligosaccharides (HMO) Segment by Grade
2.4.1 Food Grade
2.4.2 Research Grade
2.4.3 Sialylated Human Milk Oligosaccharides (HMO) Sales by Grade
2.4.3.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Grade (2021-2026)
2.4.3.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue and Market Share by Grade (2021-2026)
2.4.3.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sale Price by Grade (2021-2026)
2.5 Sialylated Human Milk Oligosaccharides (HMO) Segment by Application
2.5.1 Infant Formula
2.5.2 Food
2.5.3 Others
2.5.4 Sialylated Human Milk Oligosaccharides (HMO) Sales by Application
2.5.4.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sale Market Share by Application (2021-2026)
2.5.4.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Sialylated Human Milk Oligosaccharides (HMO) Breakdown Data by Company
3.1.1 Global Sialylated Human Milk Oligosaccharides (HMO) Annual Sales by Company (2021-2026)
3.1.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Company (2021-2026)
3.2 Global Sialylated Human Milk Oligosaccharides (HMO) Annual Revenue by Company (2021-2026)
3.2.1 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Company (2021-2026)
3.2.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Company (2021-2026)
3.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sale Price by Company
3.4 Key Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Product Location Distribution
3.4.2 Players Sialylated Human Milk Oligosaccharides (HMO) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SIALYLATED HUMAN MILK OLIGOSACCHARIDES (HMO) BY GEOGRAPHIC REGION
4.1 World Historic Sialylated Human Milk Oligosaccharides (HMO) Market Size by Geographic Region (2021-2026)
4.1.1 Global Sialylated Human Milk Oligosaccharides (HMO) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Sialylated Human Milk Oligosaccharides (HMO) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Sialylated Human Milk Oligosaccharides (HMO) Market Size by Country/Region (2021-2026)
4.2.1 Global Sialylated Human Milk Oligosaccharides (HMO) Annual Sales by Country/Region (2021-2026)
4.2.2 Global Sialylated Human Milk Oligosaccharides (HMO) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Sialylated Human Milk Oligosaccharides (HMO) Sales Growth
4.4 APAC Sialylated Human Milk Oligosaccharides (HMO) Sales Growth
4.5 Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Growth
4.6 Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Growth
5 AMERICAS
5.1 Americas Sialylated Human Milk Oligosaccharides (HMO) Sales by Country
5.1.1 Americas Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026)
5.1.2 Americas Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2021-2026)
5.2 Americas Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026)
5.3 Americas Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sialylated Human Milk Oligosaccharides (HMO) Sales by Region
6.1.1 APAC Sialylated Human Milk Oligosaccharides (HMO) Sales by Region (2021-2026)
6.1.2 APAC Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region (2021-2026)
6.2 APAC Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026)
6.3 APAC Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Sialylated Human Milk Oligosaccharides (HMO) by Country
7.1.1 Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026)
7.1.2 Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2021-2026)
7.2 Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026)
7.3 Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) by Country
8.1.1 Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026)
8.1.2 Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2021-2026)
8.2 Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026)
8.3 Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sialylated Human Milk Oligosaccharides (HMO)
10.3 Manufacturing Process Analysis of Sialylated Human Milk Oligosaccharides (HMO)
10.4 Industry Chain Structure of Sialylated Human Milk Oligosaccharides (HMO)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sialylated Human Milk Oligosaccharides (HMO) Distributors
11.3 Sialylated Human Milk Oligosaccharides (HMO) Customer
12 WORLD FORECAST REVIEW FOR SIALYLATED HUMAN MILK OLIGOSACCHARIDES (HMO) BY GEOGRAPHIC REGION
12.1 Global Sialylated Human Milk Oligosaccharides (HMO) Market Size Forecast by Region
12.1.1 Global Sialylated Human Milk Oligosaccharides (HMO) Forecast by Region (2027-2032)
12.1.2 Global Sialylated Human Milk Oligosaccharides (HMO) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Sialylated Human Milk Oligosaccharides (HMO) Forecast by Type (2027-2032)
12.7 Global Sialylated Human Milk Oligosaccharides (HMO) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novonesis
13.1.1 Novonesis Company Information
13.1.2 Novonesis Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
13.1.3 Novonesis Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novonesis Main Business Overview
13.1.5 Novonesis Latest Developments
13.2 Inbiose
13.2.1 Inbiose Company Information
13.2.2 Inbiose Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
13.2.3 Inbiose Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Inbiose Main Business Overview
13.2.5 Inbiose Latest Developments
13.3 DSM (Glycom A/S)
13.3.1 DSM (Glycom A/S) Company Information
13.3.2 DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
13.3.3 DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 DSM (Glycom A/S) Main Business Overview
13.3.5 DSM (Glycom A/S) Latest Developments
13.4 Kyowa Hakko Bio
13.4.1 Kyowa Hakko Bio Company Information
13.4.2 Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
13.4.3 Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Kyowa Hakko Bio Main Business Overview
13.4.5 Kyowa Hakko Bio Latest Developments
13.5 GeneChem Inc.
13.5.1 GeneChem Inc. Company Information
13.5.2 GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
13.5.3 GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 GeneChem Inc. Main Business Overview
13.5.5 GeneChem Inc. Latest Developments
13.6 Elicityl
13.6.1 Elicityl Company Information
13.6.2 Elicityl Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
13.6.3 Elicityl Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Elicityl Main Business Overview
13.6.5 Elicityl Latest Developments
13.7 Zhuhai Langjian Biotechnology
13.7.1 Zhuhai Langjian Biotechnology Company Information
13.7.2 Zhuhai Langjian Biotechnology Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
13.7.3 Zhuhai Langjian Biotechnology Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Zhuhai Langjian Biotechnology Main Business Overview
13.7.5 Zhuhai Langjian Biotechnology Latest Developments
13.8 Shanghai HuicH Biotech
13.8.1 Shanghai HuicH Biotech Company Information
13.8.2 Shanghai HuicH Biotech Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
13.8.3 Shanghai HuicH Biotech Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Shanghai HuicH Biotech Main Business Overview
13.8.5 Shanghai HuicH Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sialylated Human Milk Oligosaccharides (HMO) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Sialylated Human Milk Oligosaccharides (HMO) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Sialylated Human Milk Oligosaccharides (HMO) by Country/Region, 2021, 2025 & 2032
2.2 Sialylated Human Milk Oligosaccharides (HMO) Segment by Type
2.2.1 3'-Sialyllactose (3'-SL)
2.2.2 6'-Sialyllactose (6'-SL)
2.2.3 Sialylated Human Milk Oligosaccharides (HMO) Sales by Type
2.2.3.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2021-2026)
2.2.3.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sale Price by Type (2021-2026)
2.3 Sialylated Human Milk Oligosaccharides (HMO) Segment by Process
2.3.1 Microbial Fermentation
2.3.2 Enzymatic Synthesis
2.3.3 Sialylated Human Milk Oligosaccharides (HMO) Sales by Process
2.3.3.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Process (2021-2026)
2.3.3.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue and Market Share by Process (2021-2026)
2.3.3.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sale Price by Process (2021-2026)
2.4 Sialylated Human Milk Oligosaccharides (HMO) Segment by Grade
2.4.1 Food Grade
2.4.2 Research Grade
2.4.3 Sialylated Human Milk Oligosaccharides (HMO) Sales by Grade
2.4.3.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Grade (2021-2026)
2.4.3.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue and Market Share by Grade (2021-2026)
2.4.3.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sale Price by Grade (2021-2026)
2.5 Sialylated Human Milk Oligosaccharides (HMO) Segment by Application
2.5.1 Infant Formula
2.5.2 Food
2.5.3 Others
2.5.4 Sialylated Human Milk Oligosaccharides (HMO) Sales by Application
2.5.4.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sale Market Share by Application (2021-2026)
2.5.4.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Sialylated Human Milk Oligosaccharides (HMO) Breakdown Data by Company
3.1.1 Global Sialylated Human Milk Oligosaccharides (HMO) Annual Sales by Company (2021-2026)
3.1.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Company (2021-2026)
3.2 Global Sialylated Human Milk Oligosaccharides (HMO) Annual Revenue by Company (2021-2026)
3.2.1 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Company (2021-2026)
3.2.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Company (2021-2026)
3.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sale Price by Company
3.4 Key Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Product Location Distribution
3.4.2 Players Sialylated Human Milk Oligosaccharides (HMO) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SIALYLATED HUMAN MILK OLIGOSACCHARIDES (HMO) BY GEOGRAPHIC REGION
4.1 World Historic Sialylated Human Milk Oligosaccharides (HMO) Market Size by Geographic Region (2021-2026)
4.1.1 Global Sialylated Human Milk Oligosaccharides (HMO) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Sialylated Human Milk Oligosaccharides (HMO) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Sialylated Human Milk Oligosaccharides (HMO) Market Size by Country/Region (2021-2026)
4.2.1 Global Sialylated Human Milk Oligosaccharides (HMO) Annual Sales by Country/Region (2021-2026)
4.2.2 Global Sialylated Human Milk Oligosaccharides (HMO) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Sialylated Human Milk Oligosaccharides (HMO) Sales Growth
4.4 APAC Sialylated Human Milk Oligosaccharides (HMO) Sales Growth
4.5 Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Growth
4.6 Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Growth
5 AMERICAS
5.1 Americas Sialylated Human Milk Oligosaccharides (HMO) Sales by Country
5.1.1 Americas Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026)
5.1.2 Americas Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2021-2026)
5.2 Americas Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026)
5.3 Americas Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sialylated Human Milk Oligosaccharides (HMO) Sales by Region
6.1.1 APAC Sialylated Human Milk Oligosaccharides (HMO) Sales by Region (2021-2026)
6.1.2 APAC Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region (2021-2026)
6.2 APAC Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026)
6.3 APAC Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Sialylated Human Milk Oligosaccharides (HMO) by Country
7.1.1 Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026)
7.1.2 Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2021-2026)
7.2 Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026)
7.3 Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) by Country
8.1.1 Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026)
8.1.2 Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2021-2026)
8.2 Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026)
8.3 Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sialylated Human Milk Oligosaccharides (HMO)
10.3 Manufacturing Process Analysis of Sialylated Human Milk Oligosaccharides (HMO)
10.4 Industry Chain Structure of Sialylated Human Milk Oligosaccharides (HMO)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sialylated Human Milk Oligosaccharides (HMO) Distributors
11.3 Sialylated Human Milk Oligosaccharides (HMO) Customer
12 WORLD FORECAST REVIEW FOR SIALYLATED HUMAN MILK OLIGOSACCHARIDES (HMO) BY GEOGRAPHIC REGION
12.1 Global Sialylated Human Milk Oligosaccharides (HMO) Market Size Forecast by Region
12.1.1 Global Sialylated Human Milk Oligosaccharides (HMO) Forecast by Region (2027-2032)
12.1.2 Global Sialylated Human Milk Oligosaccharides (HMO) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Sialylated Human Milk Oligosaccharides (HMO) Forecast by Type (2027-2032)
12.7 Global Sialylated Human Milk Oligosaccharides (HMO) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novonesis
13.1.1 Novonesis Company Information
13.1.2 Novonesis Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
13.1.3 Novonesis Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novonesis Main Business Overview
13.1.5 Novonesis Latest Developments
13.2 Inbiose
13.2.1 Inbiose Company Information
13.2.2 Inbiose Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
13.2.3 Inbiose Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Inbiose Main Business Overview
13.2.5 Inbiose Latest Developments
13.3 DSM (Glycom A/S)
13.3.1 DSM (Glycom A/S) Company Information
13.3.2 DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
13.3.3 DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 DSM (Glycom A/S) Main Business Overview
13.3.5 DSM (Glycom A/S) Latest Developments
13.4 Kyowa Hakko Bio
13.4.1 Kyowa Hakko Bio Company Information
13.4.2 Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
13.4.3 Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Kyowa Hakko Bio Main Business Overview
13.4.5 Kyowa Hakko Bio Latest Developments
13.5 GeneChem Inc.
13.5.1 GeneChem Inc. Company Information
13.5.2 GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
13.5.3 GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 GeneChem Inc. Main Business Overview
13.5.5 GeneChem Inc. Latest Developments
13.6 Elicityl
13.6.1 Elicityl Company Information
13.6.2 Elicityl Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
13.6.3 Elicityl Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Elicityl Main Business Overview
13.6.5 Elicityl Latest Developments
13.7 Zhuhai Langjian Biotechnology
13.7.1 Zhuhai Langjian Biotechnology Company Information
13.7.2 Zhuhai Langjian Biotechnology Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
13.7.3 Zhuhai Langjian Biotechnology Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Zhuhai Langjian Biotechnology Main Business Overview
13.7.5 Zhuhai Langjian Biotechnology Latest Developments
13.8 Shanghai HuicH Biotech
13.8.1 Shanghai HuicH Biotech Company Information
13.8.2 Shanghai HuicH Biotech Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
13.8.3 Shanghai HuicH Biotech Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Shanghai HuicH Biotech Main Business Overview
13.8.5 Shanghai HuicH Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Sialylated Human Milk Oligosaccharides (HMO) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Sialylated Human Milk Oligosaccharides (HMO) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 3'-Sialyllactose (3'-SL)
Table 4. Major Players of 6'-Sialyllactose (6'-SL)
Table 5. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (Tons)
Table 6. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2021-2026)
Table 7. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2021-2026) & ($ million)
Table 8. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2021-2026)
Table 9. Global Sialylated Human Milk Oligosaccharides (HMO) Sale Price by Type (2021-2026) & (US$/Kg)
Table 10. Major Players of Microbial Fermentation
Table 11. Major Players of Enzymatic Synthesis
Table 12. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Process (2021-2026) & (Tons)
Table 13. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Process (2021-2026)
Table 14. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Process (2021-2026) & ($ million)
Table 15. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Process (2021-2026)
Table 16. Global Sialylated Human Milk Oligosaccharides (HMO) Sale Price by Process (2021-2026) & (US$/Kg)
Table 17. Major Players of Food Grade
Table 18. Major Players of Research Grade
Table 19. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Grade (2021-2026) & (Tons)
Table 20. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Grade (2021-2026)
Table 21. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Grade (2021-2026) & ($ million)
Table 22. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Grade (2021-2026)
Table 23. Global Sialylated Human Milk Oligosaccharides (HMO) Sale Price by Grade (2021-2026) & (US$/Kg)
Table 24. Global Sialylated Human Milk Oligosaccharides (HMO) Sale by Application (2021-2026) & (Tons)
Table 25. Global Sialylated Human Milk Oligosaccharides (HMO) Sale Market Share by Application (2021-2026)
Table 26. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2021-2026) & ($ million)
Table 27. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2021-2026)
Table 28. Global Sialylated Human Milk Oligosaccharides (HMO) Sale Price by Application (2021-2026) & (US$/Kg)
Table 29. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Company (2021-2026) & (Tons)
Table 30. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Company (2021-2026)
Table 31. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Company (2021-2026) & ($ millions)
Table 32. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Company (2021-2026)
Table 33. Global Sialylated Human Milk Oligosaccharides (HMO) Sale Price by Company (2021-2026) & (US$/Kg)
Table 34. Key Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Producing Area Distribution and Sales Area
Table 35. Players Sialylated Human Milk Oligosaccharides (HMO) Products Offered
Table 36. Sialylated Human Milk Oligosaccharides (HMO) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 37. New Products and Potential Entrants
Table 38. Market M&A Activity & Strategy
Table 39. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Geographic Region (2021-2026) & (Tons)
Table 40. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share Geographic Region (2021-2026)
Table 41. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 42. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Geographic Region (2021-2026)
Table 43. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Country/Region (2021-2026) & (Tons)
Table 44. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Country/Region (2021-2026)
Table 45. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country/Region (2021-2026) & ($ millions)
Table 46. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Country/Region (2021-2026)
Table 47. Americas Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (Tons)
Table 48. Americas Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2021-2026)
Table 49. Americas Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2021-2026) & ($ millions)
Table 50. Americas Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (Tons)
Table 51. Americas Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (Tons)
Table 52. APAC Sialylated Human Milk Oligosaccharides (HMO) Sales by Region (2021-2026) & (Tons)
Table 53. APAC Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2021-2026)
Table 54. APAC Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region (2021-2026) & ($ millions)
Table 55. APAC Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (Tons)
Table 56. APAC Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (Tons)
Table 57. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (Tons)
Table 58. Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2021-2026) & ($ millions)
Table 59. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (Tons)
Table 60. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (Tons)
Table 61. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (Tons)
Table 62. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2021-2026)
Table 63. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (Tons)
Table 64. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (Tons)
Table 65. Key Market Drivers & Growth Opportunities of Sialylated Human Milk Oligosaccharides (HMO)
Table 66. Key Market Challenges & Risks of Sialylated Human Milk Oligosaccharides (HMO)
Table 67. Key Industry Trends of Sialylated Human Milk Oligosaccharides (HMO)
Table 68. Sialylated Human Milk Oligosaccharides (HMO) Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Sialylated Human Milk Oligosaccharides (HMO) Distributors List
Table 71. Sialylated Human Milk Oligosaccharides (HMO) Customer List
Table 72. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Forecast by Region (2027-2032) & (Tons)
Table 73. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 74. Americas Sialylated Human Milk Oligosaccharides (HMO) Sales Forecast by Country (2027-2032) & (Tons)
Table 75. Americas Sialylated Human Milk Oligosaccharides (HMO) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. APAC Sialylated Human Milk Oligosaccharides (HMO) Sales Forecast by Region (2027-2032) & (Tons)
Table 77. APAC Sialylated Human Milk Oligosaccharides (HMO) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Forecast by Country (2027-2032) & (Tons)
Table 79. Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Forecast by Country (2027-2032) & (Tons)
Table 81. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Forecast by Type (2027-2032) & (Tons)
Table 83. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 84. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Forecast by Application (2027-2032) & (Tons)
Table 85. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 86. Novonesis Basic Information, Sialylated Human Milk Oligosaccharides (HMO) Manufacturing Base, Sales Area and Its Competitors
Table 87. Novonesis Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
Table 88. Novonesis Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 89. Novonesis Main Business
Table 90. Novonesis Latest Developments
Table 91. Inbiose Basic Information, Sialylated Human Milk Oligosaccharides (HMO) Manufacturing Base, Sales Area and Its Competitors
Table 92. Inbiose Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
Table 93. Inbiose Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 94. Inbiose Main Business
Table 95. Inbiose Latest Developments
Table 96. DSM (Glycom A/S) Basic Information, Sialylated Human Milk Oligosaccharides (HMO) Manufacturing Base, Sales Area and Its Competitors
Table 97. DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
Table 98. DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 99. DSM (Glycom A/S) Main Business
Table 100. DSM (Glycom A/S) Latest Developments
Table 101. Kyowa Hakko Bio Basic Information, Sialylated Human Milk Oligosaccharides (HMO) Manufacturing Base, Sales Area and Its Competitors
Table 102. Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
Table 103. Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 104. Kyowa Hakko Bio Main Business
Table 105. Kyowa Hakko Bio Latest Developments
Table 106. GeneChem Inc. Basic Information, Sialylated Human Milk Oligosaccharides (HMO) Manufacturing Base, Sales Area and Its Competitors
Table 107. GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
Table 108. GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 109. GeneChem Inc. Main Business
Table 110. GeneChem Inc. Latest Developments
Table 111. Elicityl Basic Information, Sialylated Human Milk Oligosaccharides (HMO) Manufacturing Base, Sales Area and Its Competitors
Table 112. Elicityl Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
Table 113. Elicityl Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 114. Elicityl Main Business
Table 115. Elicityl Latest Developments
Table 116. Zhuhai Langjian Biotechnology Basic Information, Sialylated Human Milk Oligosaccharides (HMO) Manufacturing Base, Sales Area and Its Competitors
Table 117. Zhuhai Langjian Biotechnology Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
Table 118. Zhuhai Langjian Biotechnology Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 119. Zhuhai Langjian Biotechnology Main Business
Table 120. Zhuhai Langjian Biotechnology Latest Developments
Table 121. Shanghai HuicH Biotech Basic Information, Sialylated Human Milk Oligosaccharides (HMO) Manufacturing Base, Sales Area and Its Competitors
Table 122. Shanghai HuicH Biotech Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
Table 123. Shanghai HuicH Biotech Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 124. Shanghai HuicH Biotech Main Business
Table 125. Shanghai HuicH Biotech Latest Developments
Table 1. Sialylated Human Milk Oligosaccharides (HMO) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Sialylated Human Milk Oligosaccharides (HMO) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 3'-Sialyllactose (3'-SL)
Table 4. Major Players of 6'-Sialyllactose (6'-SL)
Table 5. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (Tons)
Table 6. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2021-2026)
Table 7. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2021-2026) & ($ million)
Table 8. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2021-2026)
Table 9. Global Sialylated Human Milk Oligosaccharides (HMO) Sale Price by Type (2021-2026) & (US$/Kg)
Table 10. Major Players of Microbial Fermentation
Table 11. Major Players of Enzymatic Synthesis
Table 12. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Process (2021-2026) & (Tons)
Table 13. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Process (2021-2026)
Table 14. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Process (2021-2026) & ($ million)
Table 15. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Process (2021-2026)
Table 16. Global Sialylated Human Milk Oligosaccharides (HMO) Sale Price by Process (2021-2026) & (US$/Kg)
Table 17. Major Players of Food Grade
Table 18. Major Players of Research Grade
Table 19. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Grade (2021-2026) & (Tons)
Table 20. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Grade (2021-2026)
Table 21. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Grade (2021-2026) & ($ million)
Table 22. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Grade (2021-2026)
Table 23. Global Sialylated Human Milk Oligosaccharides (HMO) Sale Price by Grade (2021-2026) & (US$/Kg)
Table 24. Global Sialylated Human Milk Oligosaccharides (HMO) Sale by Application (2021-2026) & (Tons)
Table 25. Global Sialylated Human Milk Oligosaccharides (HMO) Sale Market Share by Application (2021-2026)
Table 26. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2021-2026) & ($ million)
Table 27. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2021-2026)
Table 28. Global Sialylated Human Milk Oligosaccharides (HMO) Sale Price by Application (2021-2026) & (US$/Kg)
Table 29. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Company (2021-2026) & (Tons)
Table 30. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Company (2021-2026)
Table 31. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Company (2021-2026) & ($ millions)
Table 32. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Company (2021-2026)
Table 33. Global Sialylated Human Milk Oligosaccharides (HMO) Sale Price by Company (2021-2026) & (US$/Kg)
Table 34. Key Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Producing Area Distribution and Sales Area
Table 35. Players Sialylated Human Milk Oligosaccharides (HMO) Products Offered
Table 36. Sialylated Human Milk Oligosaccharides (HMO) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 37. New Products and Potential Entrants
Table 38. Market M&A Activity & Strategy
Table 39. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Geographic Region (2021-2026) & (Tons)
Table 40. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share Geographic Region (2021-2026)
Table 41. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 42. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Geographic Region (2021-2026)
Table 43. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Country/Region (2021-2026) & (Tons)
Table 44. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Country/Region (2021-2026)
Table 45. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country/Region (2021-2026) & ($ millions)
Table 46. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Country/Region (2021-2026)
Table 47. Americas Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (Tons)
Table 48. Americas Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2021-2026)
Table 49. Americas Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2021-2026) & ($ millions)
Table 50. Americas Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (Tons)
Table 51. Americas Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (Tons)
Table 52. APAC Sialylated Human Milk Oligosaccharides (HMO) Sales by Region (2021-2026) & (Tons)
Table 53. APAC Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2021-2026)
Table 54. APAC Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region (2021-2026) & ($ millions)
Table 55. APAC Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (Tons)
Table 56. APAC Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (Tons)
Table 57. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (Tons)
Table 58. Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2021-2026) & ($ millions)
Table 59. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (Tons)
Table 60. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (Tons)
Table 61. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (Tons)
Table 62. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2021-2026)
Table 63. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (Tons)
Table 64. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (Tons)
Table 65. Key Market Drivers & Growth Opportunities of Sialylated Human Milk Oligosaccharides (HMO)
Table 66. Key Market Challenges & Risks of Sialylated Human Milk Oligosaccharides (HMO)
Table 67. Key Industry Trends of Sialylated Human Milk Oligosaccharides (HMO)
Table 68. Sialylated Human Milk Oligosaccharides (HMO) Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Sialylated Human Milk Oligosaccharides (HMO) Distributors List
Table 71. Sialylated Human Milk Oligosaccharides (HMO) Customer List
Table 72. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Forecast by Region (2027-2032) & (Tons)
Table 73. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 74. Americas Sialylated Human Milk Oligosaccharides (HMO) Sales Forecast by Country (2027-2032) & (Tons)
Table 75. Americas Sialylated Human Milk Oligosaccharides (HMO) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. APAC Sialylated Human Milk Oligosaccharides (HMO) Sales Forecast by Region (2027-2032) & (Tons)
Table 77. APAC Sialylated Human Milk Oligosaccharides (HMO) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Forecast by Country (2027-2032) & (Tons)
Table 79. Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Forecast by Country (2027-2032) & (Tons)
Table 81. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Forecast by Type (2027-2032) & (Tons)
Table 83. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 84. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Forecast by Application (2027-2032) & (Tons)
Table 85. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 86. Novonesis Basic Information, Sialylated Human Milk Oligosaccharides (HMO) Manufacturing Base, Sales Area and Its Competitors
Table 87. Novonesis Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
Table 88. Novonesis Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 89. Novonesis Main Business
Table 90. Novonesis Latest Developments
Table 91. Inbiose Basic Information, Sialylated Human Milk Oligosaccharides (HMO) Manufacturing Base, Sales Area and Its Competitors
Table 92. Inbiose Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
Table 93. Inbiose Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 94. Inbiose Main Business
Table 95. Inbiose Latest Developments
Table 96. DSM (Glycom A/S) Basic Information, Sialylated Human Milk Oligosaccharides (HMO) Manufacturing Base, Sales Area and Its Competitors
Table 97. DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
Table 98. DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 99. DSM (Glycom A/S) Main Business
Table 100. DSM (Glycom A/S) Latest Developments
Table 101. Kyowa Hakko Bio Basic Information, Sialylated Human Milk Oligosaccharides (HMO) Manufacturing Base, Sales Area and Its Competitors
Table 102. Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
Table 103. Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 104. Kyowa Hakko Bio Main Business
Table 105. Kyowa Hakko Bio Latest Developments
Table 106. GeneChem Inc. Basic Information, Sialylated Human Milk Oligosaccharides (HMO) Manufacturing Base, Sales Area and Its Competitors
Table 107. GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
Table 108. GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 109. GeneChem Inc. Main Business
Table 110. GeneChem Inc. Latest Developments
Table 111. Elicityl Basic Information, Sialylated Human Milk Oligosaccharides (HMO) Manufacturing Base, Sales Area and Its Competitors
Table 112. Elicityl Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
Table 113. Elicityl Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 114. Elicityl Main Business
Table 115. Elicityl Latest Developments
Table 116. Zhuhai Langjian Biotechnology Basic Information, Sialylated Human Milk Oligosaccharides (HMO) Manufacturing Base, Sales Area and Its Competitors
Table 117. Zhuhai Langjian Biotechnology Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
Table 118. Zhuhai Langjian Biotechnology Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 119. Zhuhai Langjian Biotechnology Main Business
Table 120. Zhuhai Langjian Biotechnology Latest Developments
Table 121. Shanghai HuicH Biotech Basic Information, Sialylated Human Milk Oligosaccharides (HMO) Manufacturing Base, Sales Area and Its Competitors
Table 122. Shanghai HuicH Biotech Sialylated Human Milk Oligosaccharides (HMO) Product Portfolios and Specifications
Table 123. Shanghai HuicH Biotech Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 124. Shanghai HuicH Biotech Main Business
Table 125. Shanghai HuicH Biotech Latest Developments
LIST OF FIGURES
Figure 1. Picture of Sialylated Human Milk Oligosaccharides (HMO)
Figure 2. Sialylated Human Milk Oligosaccharides (HMO) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Sialylated Human Milk Oligosaccharides (HMO) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Country/Region (2025)
Figure 10. Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 3'-Sialyllactose (3'-SL)
Figure 12. Product Picture of 6'-Sialyllactose (6'-SL)
Figure 13. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type in 2026
Figure 14. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Microbial Fermentation
Figure 16. Product Picture of Enzymatic Synthesis
Figure 17. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Process in 2026
Figure 18. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Process (2021-2026)
Figure 19. Product Picture of Food Grade
Figure 20. Product Picture of Research Grade
Figure 21. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Grade in 2026
Figure 22. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Grade (2021-2026)
Figure 23. Sialylated Human Milk Oligosaccharides (HMO) Consumed in Infant Formula
Figure 24. Global Sialylated Human Milk Oligosaccharides (HMO) Market: Infant Formula (2021-2026) & (Tons)
Figure 25. Sialylated Human Milk Oligosaccharides (HMO) Consumed in Food
Figure 26. Global Sialylated Human Milk Oligosaccharides (HMO) Market: Food (2021-2026) & (Tons)
Figure 27. Sialylated Human Milk Oligosaccharides (HMO) Consumed in Others
Figure 28. Global Sialylated Human Milk Oligosaccharides (HMO) Market: Others (2021-2026) & (Tons)
Figure 29. Global Sialylated Human Milk Oligosaccharides (HMO) Sale Market Share by Application (2025)
Figure 30. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Application in 2025
Figure 31. Sialylated Human Milk Oligosaccharides (HMO) Sales by Company in 2025 (Tons)
Figure 32. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Company in 2025
Figure 33. Sialylated Human Milk Oligosaccharides (HMO) Revenue by Company in 2025 ($ millions)
Figure 34. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Company in 2025
Figure 35. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Geographic Region (2021-2026)
Figure 36. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Geographic Region in 2025
Figure 37. Americas Sialylated Human Milk Oligosaccharides (HMO) Sales 2021-2026 (Tons)
Figure 38. Americas Sialylated Human Milk Oligosaccharides (HMO) Revenue 2021-2026 ($ millions)
Figure 39. APAC Sialylated Human Milk Oligosaccharides (HMO) Sales 2021-2026 (Tons)
Figure 40. APAC Sialylated Human Milk Oligosaccharides (HMO) Revenue 2021-2026 ($ millions)
Figure 41. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales 2021-2026 (Tons)
Figure 42. Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue 2021-2026 ($ millions)
Figure 43. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales 2021-2026 (Tons)
Figure 44. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Revenue 2021-2026 ($ millions)
Figure 45. Americas Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Country in 2025
Figure 46. Americas Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2021-2026)
Figure 47. Americas Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2021-2026)
Figure 48. Americas Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2021-2026)
Figure 49. United States Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 50. Canada Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 51. Mexico Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 52. Brazil Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 53. APAC Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Region in 2025
Figure 54. APAC Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2021-2026)
Figure 55. APAC Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2021-2026)
Figure 56. APAC Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2021-2026)
Figure 57. China Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 58. Japan Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 59. South Korea Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 60. Southeast Asia Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 61. India Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 62. Australia Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 63. China Taiwan Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 64. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Country in 2025
Figure 65. Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2021-2026)
Figure 66. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2021-2026)
Figure 67. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2021-2026)
Figure 68. Germany Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 69. France Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 70. UK Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 71. Italy Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 72. Russia Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 73. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2021-2026)
Figure 74. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2021-2026)
Figure 75. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2021-2026)
Figure 76. Egypt Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 77. South Africa Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 78. Israel Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 79. Turkey Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 80. GCC Countries Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of Sialylated Human Milk Oligosaccharides (HMO) in 2026
Figure 82. Manufacturing Process Analysis of Sialylated Human Milk Oligosaccharides (HMO)
Figure 83. Industry Chain Structure of Sialylated Human Milk Oligosaccharides (HMO)
Figure 84. Channels of Distribution
Figure 85. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Forecast by Region (2027-2032)
Figure 86. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share Forecast by Region (2027-2032)
Figure 87. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share Forecast by Type (2027-2032)
Figure 88. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share Forecast by Type (2027-2032)
Figure 89. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share Forecast by Application (2027-2032)
Figure 90. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Sialylated Human Milk Oligosaccharides (HMO)
Figure 2. Sialylated Human Milk Oligosaccharides (HMO) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Sialylated Human Milk Oligosaccharides (HMO) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Country/Region (2025)
Figure 10. Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 3'-Sialyllactose (3'-SL)
Figure 12. Product Picture of 6'-Sialyllactose (6'-SL)
Figure 13. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type in 2026
Figure 14. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Microbial Fermentation
Figure 16. Product Picture of Enzymatic Synthesis
Figure 17. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Process in 2026
Figure 18. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Process (2021-2026)
Figure 19. Product Picture of Food Grade
Figure 20. Product Picture of Research Grade
Figure 21. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Grade in 2026
Figure 22. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Grade (2021-2026)
Figure 23. Sialylated Human Milk Oligosaccharides (HMO) Consumed in Infant Formula
Figure 24. Global Sialylated Human Milk Oligosaccharides (HMO) Market: Infant Formula (2021-2026) & (Tons)
Figure 25. Sialylated Human Milk Oligosaccharides (HMO) Consumed in Food
Figure 26. Global Sialylated Human Milk Oligosaccharides (HMO) Market: Food (2021-2026) & (Tons)
Figure 27. Sialylated Human Milk Oligosaccharides (HMO) Consumed in Others
Figure 28. Global Sialylated Human Milk Oligosaccharides (HMO) Market: Others (2021-2026) & (Tons)
Figure 29. Global Sialylated Human Milk Oligosaccharides (HMO) Sale Market Share by Application (2025)
Figure 30. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Application in 2025
Figure 31. Sialylated Human Milk Oligosaccharides (HMO) Sales by Company in 2025 (Tons)
Figure 32. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Company in 2025
Figure 33. Sialylated Human Milk Oligosaccharides (HMO) Revenue by Company in 2025 ($ millions)
Figure 34. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Company in 2025
Figure 35. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Geographic Region (2021-2026)
Figure 36. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Geographic Region in 2025
Figure 37. Americas Sialylated Human Milk Oligosaccharides (HMO) Sales 2021-2026 (Tons)
Figure 38. Americas Sialylated Human Milk Oligosaccharides (HMO) Revenue 2021-2026 ($ millions)
Figure 39. APAC Sialylated Human Milk Oligosaccharides (HMO) Sales 2021-2026 (Tons)
Figure 40. APAC Sialylated Human Milk Oligosaccharides (HMO) Revenue 2021-2026 ($ millions)
Figure 41. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales 2021-2026 (Tons)
Figure 42. Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue 2021-2026 ($ millions)
Figure 43. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales 2021-2026 (Tons)
Figure 44. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Revenue 2021-2026 ($ millions)
Figure 45. Americas Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Country in 2025
Figure 46. Americas Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2021-2026)
Figure 47. Americas Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2021-2026)
Figure 48. Americas Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2021-2026)
Figure 49. United States Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 50. Canada Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 51. Mexico Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 52. Brazil Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 53. APAC Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Region in 2025
Figure 54. APAC Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2021-2026)
Figure 55. APAC Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2021-2026)
Figure 56. APAC Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2021-2026)
Figure 57. China Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 58. Japan Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 59. South Korea Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 60. Southeast Asia Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 61. India Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 62. Australia Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 63. China Taiwan Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 64. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Country in 2025
Figure 65. Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2021-2026)
Figure 66. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2021-2026)
Figure 67. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2021-2026)
Figure 68. Germany Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 69. France Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 70. UK Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 71. Italy Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 72. Russia Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 73. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2021-2026)
Figure 74. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2021-2026)
Figure 75. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2021-2026)
Figure 76. Egypt Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 77. South Africa Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 78. Israel Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 79. Turkey Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 80. GCC Countries Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth 2021-2026 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of Sialylated Human Milk Oligosaccharides (HMO) in 2026
Figure 82. Manufacturing Process Analysis of Sialylated Human Milk Oligosaccharides (HMO)
Figure 83. Industry Chain Structure of Sialylated Human Milk Oligosaccharides (HMO)
Figure 84. Channels of Distribution
Figure 85. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Forecast by Region (2027-2032)
Figure 86. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share Forecast by Region (2027-2032)
Figure 87. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share Forecast by Type (2027-2032)
Figure 88. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share Forecast by Type (2027-2032)
Figure 89. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share Forecast by Application (2027-2032)
Figure 90. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share Forecast by Application (2027-2032)
